Charles Theuer, President and CEO at Tracon Pharmaceuticals, Inc. (TCON), bought 11,000 shares at $8.98 ($99K) on 2021-01-27, disclosed to the SEC on 2021-01-28.
Seasonal purchase ($99k) by President and CEO — this insider has traded TCON in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| TCON | BUY | 2023-01-19 | $11K | — | Filing → |
| TCON | BUY | 2022-12-15 | $30K | — | Filing → |
| TCON | BUY | 2022-11-22 | $20K | — | Filing → |